Nutreco acquires minority stake in Fishers company
A European animal nutrition company has acquired a minority stake in Fishers-based BiomEdit. Nutreco, headquartered in the Netherlands, is not disclosing the amount of its financial investment but said it is part of BiomEdit’s $40 million Series A funding round announced last year.
BiomEdit develops new products derived from microbiomes that are designed to promote animal health without the use of antibiotics.
The company spun out of Elanco Animal Health Inc. (NYSE: ELAN) in Greenfield last April with its Series A round. A spokesperson for Nutreco told IIB the company is the final investor in the funding round, which is now successfully closed.
The announcement comes a month after the two companies inked a long-term research and commercial partnership designed to develop novel feed additives for livestock using microbiome technology.
Nutreco said the investment will help fuel all aspects of the innovation process to discover, develop and commercialize a new category of “Biome-actives.”
“Through this investment, we are reinforcing the unique collaboration that brings together BiomEdit’s state-of-the-art microbiome discovery platform and Nutreco’s customer access and distribution capabilities,” Nutreco CEO Fulco van Lede said in a news release. “We’re excited about its potential to help us super-charge our supply of proprietary ultra-specialty ingredients, speed up progress on our purpose of Feeding the Future and create a more sustainable future for our industry.”
The Series A round also included investments from Anterra Capital in Amsterdam and Boston; Viking Global Investors, which has offices in New York, Connecticut and California; and venture capital firm Ferment.
Last June, BiomEdit announced plans to establish its global headquarters in Fishers.